Pain and Morphea

Summary:

Morphea is found among people with Pain, especially for people who are female, 50-59 old.

The study analyzes which people have Morphea with Pain. It is created by eHealthMe based on reports of 16 people who have Pain from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pain?

Pain is found to be associated with 3,809 drugs and 5,870 conditions by eHealthMe. Check the latest studies of Pain.

What is Morphea?

Morphea is found to be associated with 57 drugs and 132 conditions by eHealthMe. Check the latest studies of Morphea.



On Aug, 05, 2026

16 people who have Pain and Morphea are studied.

Would you have Morphea when you have Pain?

Gender of people who have Pain and experienced Morphea *:

  • female: 68.75 %
  • male: 31.25 %

Age of people who have Pain and experienced Morphea *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 81.82 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 43.75%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 37.50%
  3. Nuclear Magnetic Resonance Imaging Abdominal: 6 people, 37.50%
  4. Type 2 Diabetes: 3 people, 18.75%
  5. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 18.75%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 18.75%
  7. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 18.75%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 18.75%
  9. Gastric Disorder (disease of stomach): 3 people, 18.75%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 12.50%

Common drugs taken by these people *:

  1. Omniscan: 8 people, 50.00%
  2. Magnevist: 8 people, 50.00%
  3. Sensipar: 7 people, 43.75%
  4. Ambien: 7 people, 43.75%
  5. Optimark: 7 people, 43.75%
  6. Protonix: 7 people, 43.75%
  7. Renagel: 6 people, 37.50%
  8. Tracleer: 6 people, 37.50%
  9. Folic Acid: 6 people, 37.50%
  10. Darvocet: 6 people, 37.50%

Common symptoms for these people *:

  1. Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 8 people, 50.00%
  2. Oedema Peripheral (superficial swelling): 8 people, 50.00%
  3. Skin Tightness: 8 people, 50.00%
  4. Skin Induration (an abnormally hard spot or area on the skin): 8 people, 50.00%
  5. Skin Hypertrophy (skin cells enlarges): 8 people, 50.00%
  6. Skin Disorder (skin disease): 7 people, 43.75%
  7. Dry Skin: 7 people, 43.75%
  8. Dyspnea (difficult or laboured breathing): 7 people, 43.75%
  9. Mobility Decreased (ability to move is reduced): 7 people, 43.75%
  10. Joint Range Of Motion Decreased (disease of joint movement): 7 people, 43.75%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Morphea?

- Check whether Morphea is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Morphea:

All the conditions that are associated with Morphea:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Morphea and Pain, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: